As reported, plasma contents of Interleukin-1β (IL-1β) and total α-syn are higher in PD patients than in controls, and both IL-1β and α-syn contents are positively linked to the severity of motor injury in PD patients [17]. Here, IL1B is linked to Parkinson disease.